Vivasure Medical Announces $18.3 million in Financing to Advance Commercialization of Closure Device in European Union and United States

News The device, part of the company's PerQseal technology platform, is a fully bioabsorbable, sutureless and entirely synthetic option to close large-bore arteriotomies that result from percutaneous transcatheter procedures. Contributed Author:  Vivasure Medical Topics:  Surgical